Both in Pharmaceuticals
Edesa Biotech vs IGC Pharma
Over the past year EDSA returned +18.5% and IGC returned −42.3%; their daily moves had a correlation of 0.06.
EDSA +18.5% IGC −42.3%Growth of $1, one year, split-adjusted
| Metric | EDSA | IGC |
|---|---|---|
| Price | $2.56 | $0.2387 |
| Market cap | $24.7M | $24.7M |
| Today | −2.66% | −3.71% |
| 1 month | −28.1% | −10.8% |
| 6 months | −83.9% | −23.0% |
| Year to date | +80.3% | −15.2% |
| 1 year | −2.7% | −43.1% |
| Revenue growth (YoY) | — | −19.2% |
| Gross margin | — | 18.1% |
| Net margin | — | −1107.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.3M | -$728.0K |
| Dividend yield | — | — |
| Volatility (60d) | 87.9% | 50.1% |
| Short % of float | 2.3% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).